MacroGenics, Inc. (MGNX) financial statements and ratios from SEC XBRL: revenue $149.50M (TTM), net margin -49.9%, revenue growth -0.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $149.50M |
| Net Margin | -49.9% |
| Revenue Growth (YoY) | -0.3% |
| EPS Growth (YoY) | 10.3% |
| FCF Growth (YoY) | 15.1% |
| Price / Book | 6.00 |
| Price / Sales | 1.75 |
| FCF Yield | -107.2% |
| Altman Z-Score | -5.54 (distress) |
| Sector P/E (Healthcare) | 21.7 |
MGNX overview · MGNX earnings · MGNX KPIs · MGNX investor relations · MGNX ownership · MGNX peers · MGNX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.